← all vendors

TraceLink

AI score: 58 / 100 Proceed with caution

Supply chain serialization and traceability for pharma and life sciences

Type: large / corporate, open / custom platform  ·  Tech: modern  ·  Budget: enterprise ($350k+)
Core verticals: pharma / nutraceutical, medical / bioscience
Functions: quality, EDI, reporting / BI

Pharmaceutical serialization and traceability network for DSCSA compliance and global track-and-trace. The dominant network in pharma supply-chain compliance — a specialized, enterprise-scale system.

editor's note: Highly specialized pharma compliance infrastructure. Relevant only if DSCSA serialization is a regulatory requirement for you.

The market-leading solution for pharmaceutical DSCSA compliance and global track-and-trace serialization. If you manufacture regulated pharmaceuticals in the US, DSCSA compliance is mandatory — TraceLink is the established partner network for that compliance. Irrelevant to non-pharma manufacturers. Score reflects narrow applicability and SMB inaccessibility.

AI score breakdown — 6 dimensions

SMB implementability 25%20
Enterprise pharma manufacturers. DSCSA compliance implementation 6-12 months. Network onboarding for trading partners required.
Purpose fit 20%88
DSCSA serialization and traceability, lot-level visibility, product digitization, and global regulatory compliance for 50+ countries.
Tech modernity 20%78
Cloud-native network. TraceLink Opus platform is modern SaaS. 200,000+ pharma network connections.
Documentation quality 15%75
Extensive DSCSA compliance documentation. Regulatory guidance library. Implementation methodology.
Real user sentiment 10%72
Pharmaceutical manufacturers rely on TraceLink as infrastructure. DSCSA compliance mandated by FDA.
TCO transparency 10%18
Enterprise pharma contracts. No public pricing. All through TraceLink sales.

Sources consulted

validate / explore this score: Perplexity ChatGPT Claude Google